Carbapenem resistance in Canada

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 12, 2009, Pages 1225-1226

  Toye, Baldwin ^a,b   Krajden, Sigmund ^c,d   Fuksa, Milan ^c   Low, Donald E ^b,d,e   Pillai, Dylan R ^b,d,e  

^a UNIVERSITY OF OTTAWA   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; CARBAPENEM; CARBAPENEMASE; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; IMIPENEM; MEROPENEM; QUINOLONE DERIVATIVE; TIGECYCLINE; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE 2, KLEBSIELLA PNEUMONIAE; CARBAPENEMASE-2, KLEBSIELLA PNEUMONIAE;

ARTICLE; CANADA; CITROBACTER; ENTEROBACTERIACEAE INFECTION; EPIDEMIC; ESCHERICHIA COLI INFECTION; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; NEPHROTOXICITY; NEUROTOXICITY; PREVALENCE; SALMONELLOSIS; ANTIBIOTIC RESISTANCE; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CANADA; CARBAPENEMS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE;

EID: 67649148037     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.090167     Document Type: Article

References (21)

1. Walther-Rasmussen J, Høiby N. Class A carbapenemases. J Antimicrob Chemother 2007;60:470-82.
2. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007;20:440-58.
3. Urban C, Bradford PA, Tuckman M, et al. Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase β-lactamases associated with long-term care facilities. Clin Infect Dis 2008;46:e127-30.
4. Bradford PA, Bratu S, Urban C, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitorresistant TEM-30β-lactamases in New York City. Clin Infect Dis 2004;39:55-60.
5. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City. Arch Intern Med 2005;165:1430-5.
6. Woodford N, Zhang J, Warner M, et al. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 2008;62:1261-4.
7. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028-33.
8. Villegas MV, Lolans K, Correa A, et al.; Colombian Nosocomial Resistance Study Group. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 2006;50:2880-2.
9. Tsakris A, Kristo I, Poulou A, et al. First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J Antimicrob Chemother 2008;62:1257-60.
10. Patel G, Huprikar S, Factor SH, et al. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-106.
11. Pillai DR, Melano R, Rawte P, et al. Klebsiella pneumoniae carbapenemase, Canada [letter]. Emerg Infect Dis 2009;15(5). Available: www.cdc.gov/EID /content/15/5/827.htm (accessed 2009 Apr. 28).
12. Goldfarb D, Harvey SB, Jessamine K, et al. Detection of plasmid mediated KPC-producing Klebsiella pneumoniae in Ottawa, Canada: evidence of intra-hospital transmission. J Clin Microbiol 2009 Apr. 8 [Epub ahead of print].
13. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Wayne (PA): The Institute; 2009. Available: www.clsi.org/source/orders/free/ m100-s19.pdf (accessed 2009 Apr. 28).
14. Cole JM, Schuetz AN, Hill CE, et al. Development and evaluation of a real-time PCR assay for the detection of Klebsiella pneumoniae carbapenemase genes. J Clin Microbiol 2009;47:322-6. Epub 2008 Nov. 26.
15. Anderson KF, Lonsway DR, Rasheed JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007;45:2723-5.
16. McGettigan SE, Andreaecchio K, Edelstein PH. Specificity of ertapenem susceptibility screening for the detection of Klebsiella pneumoniae carbapenemases (KPC). J Clin Microbiol 2009;47:785-6. Epub 2009 Jan. 14
17. Pitout JD. Multiresistant Enterobacteriaceae: new threat of an old problem. Expert Rev Anti Infect Ther 2008;6:657-69.
18. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41.
19. Bratu S, Tolaney P, Karumudi U, et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005;56:128-32.
20. Srinivasan A., Patel J.B. Klebsiella pneumoniae carbapenemase-producing organisms: An ounce of prevention really is worth a pound of cure. Infect Control Hosp Epidemiol 2008;29:1107-9.
21. Dellit TH, Owens RC, McGowan JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship. Clin Infect Dis 2007;44:159-77.